Information for people from Europe

For everything that is related to Lyme and/or Lymeland, but doesn't fit in the other forums. Speak your mind, connect, ask help, etc.
X-member
Posts: 3053
Joined: Mon 30 Jul 2007 18:18

Re: Information for people from Europe

Postby X-member » Sat 12 Mar 2016 18:49

An estimate of Lyme borreliosis incidence in Western Europe†. (2016)

http://www.ncbi.nlm.nih.gov/pubmed/26966194

Two quotes:

The highest reported incidences for LB were reported in southern Sweden with 464/100 000 and the lowest in Italy of 0.001/100 000.


LB is a continually emerging disease and the most common zoonotic infection in Western Europe approaching endemic proportions in many European countries.

X-member
Posts: 3053
Joined: Mon 30 Jul 2007 18:18

Re: Information for people from Europe

Postby X-member » Tue 4 Oct 2016 17:03

Statement of the BCA-clinic on the documentary entitled “Snyd eller Borrelia” of the Danish channel TV2 on 29.09.2016 | October 01, 2016

http://www.bca-clinic.de/statement-of-t ... 9-09-2016/

A quote:

However, our laboratory currently always performs tests irrespective of whether it would be possible to mark the difference between “Borrelia” and “Lyme borreliosis” more strongly in order to ensure to an even greater extent that even a person who is not an English native speaker can recognize the difference immediately.



My comment: I use to call the disease borreliosis because borrelia is the name of the bacterium.

X-member
Posts: 3053
Joined: Mon 30 Jul 2007 18:18

Re: Information for people from Europe

Postby X-member » Sun 16 Jul 2017 15:18

Eurosurveillance, Volume 22, Issue 27, 06 July 2017

Perspective
SURVEILLANCE PERSPECTIVE ON LYME BORRELIOSIS ACROSS THE EUROPEAN UNION AND EUROPEAN ECONOMIC AREA

CC van den Wijngaard 1 , A Hofhuis 1 , M Simões 1 , E Rood 2 , W van Pelt 1 , H Zeller 3 , W Van Bortel 4 5


http://www.eurosurveillance.org/ViewArt ... leId=22831

A quote:

Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe. Erythema migrans (EM), an early, localised skin rash, is its most common presentation. Dissemination of the bacteria can lead to more severe manifestations including skin, neurological, cardiac, musculoskeletal and ocular manifestations. Comparison of LB incidence rates in the European Union (EU)/European Economic Area (EEA) and Balkan countries are difficult in the absence of standardised surveillance and reporting procedures. We explored six surveillance scenarios for LB surveillance in the EU/EEA, based on the following key indicators: (i) erythema migrans, (ii) neuroborreliosis, (iii) all human LB manifestations, (iv) seroprevalence, (v) tick bites, and (vi) infected ticks and reservoir hosts. In our opinion, neuroborreliosis seems most feasible and useful as the standard key indicator, being one of the most frequent severe LB manifestations, with the possibility of a specific case definition. Additional surveillance with erythema migrans as key indicator would add value to the surveillance of neuroborreliosis and lead to a more complete picture of LB epidemiology in the EU/EEA. The other scenarios have less value as a basis for EU-level surveillance, but can be considered periodically and locally, as they could supply complementary insights.

X-member
Posts: 3053
Joined: Mon 30 Jul 2007 18:18

Re: Information for people from Europe

Postby X-member » Sat 11 Aug 2018 14:45

EDITORIAL| VOLUME 392, ISSUE 10146, P452, AUGUST 11, 2018
PDF [178 KB]

Introducing EU-wide surveillance of Lyme neuroborreliosis
The Lancet

DOI:https://doi.org/10.1016/S0140-6736(18)31738-0


https://www.thelancet.com/journals/lanc ... 40-6736(18)31738-0/fulltext

TinyUrl (if the link above don't work):

https://tinyurl.com/yalhdgak

Quote:

On June 22, 2018, the European Commission issued an updated list of communicable diseases to be covered by epidemiological surveillance in the EU. This list now includes Lyme neuroborreliosis, the neurological manifestation of Lyme borreliosis, which is caused by tick-borne Borrelia burgdorferi sensu lato infection. The decision authorises the European Centre for Disease Prevention and Control (ECDC) to begin monitoring the EU-wide distribution of Lyme neuroborreliosis cases.

The population-weighted incidence of Lyme borreliosis in western Europe has been estimated at 22 cases per 100 000 person-years, but the quality and quantity of incidence data from European countries varies. Variations in country-specific disease burden will reflect the geographical distribution of tick populations, but the absence of a consensus case definition and reporting procedures has prevented disease trends from being accurately assessed. Lyme neuroborreliosis is not a notifiable disease in all European countries, and diagnostic difficulties muddle the reported incidence data.

A new uniform EU case definition lists neurological symptoms, as described in the European Federation of Neurological Societies' guidelines, and laboratory-confirmed CSF infection as criteria for probable and confirmed cases of Lyme neuroborreliosis. The adoption of this case definition by national laboratories and doctors across Europe will reduce case under-reporting and misclassification; however, the laboratory tests might not be standard in all EU countries. Neuroborreliosis is also relatively rare compared with other manifestations, such as erythema migrans, so surveillance of neuroborreliosis might be relatively insensitive.

The risk of Lyme borreliosis is expected to increase as tick habitats expand in response to environmental factors and climate change. The systematic acquisition of data from across Europe is a fundamental first step towards quantifying temporal and spatial trends in disease burden and will help clarify the real extent of Lyme neuroborreliosis and define public health resources for prevention methods and control research.


Return to “Lyme Café”

Who is online

Users browsing this forum: Trendiction [Bot] and 2 guests